Edition:
United States

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

11.15USD
4:00pm EDT
Change (% chg)

$-0.15 (-1.33%)
Prev Close
$11.30
Open
$11.20
Day's High
$11.20
Day's Low
$10.75
Volume
5,207
Avg. Vol
7,243
52-wk High
$11.55
52-wk Low
$5.75

Chart for

About

Chembio Diagnostics, Inc. (Chembio), and its subsidiary, Chembio Diagnostic Systems, Inc., develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company's products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies,... (more)

Overall

Beta: 1.23
Market Cap(Mil.): $160.75
Shares Outstanding(Mil.): 14.16
Dividend: --
Yield (%): --

Financials

  CEMI.OQ Industry Sector
P/E (TTM): -- 28.11 30.17
EPS (TTM): -0.38 -- --
ROI: -25.78 12.95 12.67
ROE: -26.54 14.96 14.86

BRIEF-Chembio Diagnostics Reports Q1 Loss Per Share $0.05

* CHEMBIO DIAGNOSTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 09 2018

BRIEF-Chembio Diagnostics And Lumiradx Enter Collaboration To Develop New Point-Of-Care Diagnostic Tests For Infectious Diseases

* CHEMBIO DIAGNOSTICS AND LUMIRADX ENTER COLLABORATION TO DEVELOP NEW POINT-OF-CARE DIAGNOSTIC TESTS FOR INFECTIOUS DISEASES

Apr 25 2018

BRIEF-Chembio Diagnostics Q4 Loss Per Share $0.16

* CHEMBIO DIAGNOSTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 08 2018

Competitors

Earnings vs. Estimates